Dosage Form: Formes inhalées comprenant les inhalateurs de poudre sèche (DPI) et les solutions/suspensions pour inhalation à visée pulmonaire et nasale
Bioavailability Enhancement: Développement de la formulation et du procédé axé sur l'optimisation du dépôt et de l'absorption pulmonaires et nasaux, appuyé par une expertise approfondie en administration inhalée
Scale Capability: Fabrication et approvisionnement clinique couvrant les phases I à III, appuyés par des équipements de séchage par atomisation, micronisation, mélange et encapsulation

Autres informations

Description supplémentaire:

With a 30-year track record in developing and manufacturing inhaled drug products, this team has experience across delivery platforms including dry powder inhalers (DPIs) and inhalation solutions/suspensions. Integrated capabilities and deep nasal and pulmonary delivery expertise help clients move molecules from first-in-human studies through proof of concept and into full development, covering pre-formulation and API characterization, formulation and process development, inhaled device evaluation and selection, clinical manufacturing and supply across Phases I-III, and clinical pharmacology assessments, supported by a wide range of processing and analytical equipment including spray drying, micronization, and blending and encapsulation.